SPHK1 and melanoma: For example, the cisplatin‐resistant melanoma cells treated with FTY720 might activated p53‐independent caspase and caused SPHK1 degradation and might inhibit the Akt/mTOR pathway.54 In another way, not all relevant features of FTY720 are helpful for cancer treatment.